These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37032266)

  • 1. Letter to the Editor Reply: Kleebayoon et al.
    Meador CB; Gainor JF
    Clin Lung Cancer; 2023 Jul; 24(5):e162-e163. PubMed ID: 37032266
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Letter to the Editor by Amnuay Kleebayoon, Viroj Wiwanitkit titled: Hesitancy toward vaccination against COVID-19.
    Alam Z; Mohamed S; Nauman J; Al-Rifai RH; Ahmed LA; Elbarazi I
    Hum Vaccin Immunother; 2023 Dec; 19(3):2270847. PubMed ID: 37853518
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to kleebayoon et al.
    Matsumoto K; Uchida F
    Eur J Cardiothorac Surg; 2024 Oct; ():. PubMed ID: 39383174
    [No Abstract]   [Full Text] [Related]  

  • 4. Comments to the Letter to the Editor of S. Shahsavari et al. concerning "Predicting medical complications in spine surgery: evaluation of a novel online risk calculator" by M. F. Kasparek et al. (Eur Spine J: doi:10.1007/s00586-018-5707-9) and the reply to the Letter to the Editor of S. Shahsavari et al. concerning "Predicting medical complications in spine surgery: evaluation of a novel online risk calculator" by M. F. Kasparek et al. (Eur Spine J: doi:10.1007/s00586-018-5707-9).
    Edwards KL
    Eur Spine J; 2018 Nov; 27(11):2889-2890. PubMed ID: 30327911
    [No Abstract]   [Full Text] [Related]  

  • 5. In reply to the letter to the editor 'in Reply to Gandaglia et al.' by De Bari et al.
    Gandaglia G; Karakiewicz PI; Briganti A; Menon M; Sun M; Abdollah F
    Ann Oncol; 2014 Sep; 25(9):1862-1863. PubMed ID: 24914042
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to letter to the editor by Riquelme LF et al. entitled 'IDDSI letter to the editor'.
    Rothenberg E; Bischoff SC; Thibault R
    Clin Nutr; 2022 May; 41(5):1142-1143. PubMed ID: 35393142
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter to the Editor From Kleebayoon and Wiuwanikit: "Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study".
    Kleebayoon A; Wiwanitkit V
    J Clin Endocrinol Metab; 2023 Dec; 109(1):e432. PubMed ID: 37463482
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to Letter to the Editor From Kleebayoon and Wiuwanikit: "Subacute THYROiditis Related to SARS-CoV-2 Vaccine and COVID-19 (THYROVAC Study): A Multicenter Nationwide Study".
    Ağbaht K; Şahin M
    J Clin Endocrinol Metab; 2023 Dec; 109(1):e436. PubMed ID: 37554094
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to the Letter to the Editor 'Germline-somatic fluidity in guiding patient care. Reply to the Letter to the Editor "Choice of control tissue impacts designation of germline variants in a cohort of papillary thyroid carcinoma patients" by J. C. Rubinstein et al.' by E. Hahn & G. S. Charames.
    Christison-Lagay ER; Rubinstein JC
    Ann Oncol; 2020 Aug; 31(8):1090-1091. PubMed ID: 32428551
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to the letter to the editor 'Reply to Solinas et al, venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review' by Frere et al.
    Petrelli F; Solinas C
    Thromb Res; 2021 Dec; 208():217-218. PubMed ID: 33810866
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter re: Letter to the Editor: Reply to Srihari et al.
    Portelli Tremont JN; Kratzke IM
    Am Surg; 2024 Jan; 90(1):159. PubMed ID: 34472990
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Letter to the Editor: P. van Damme et al., Vaccine 34 (2016) 757-761, as a reply to Ryser et al's letter in Vaccine.
    Van Damme P; Stanley M
    Vaccine; 2016 Aug; 34(36):4272. PubMed ID: 27452650
    [No Abstract]   [Full Text] [Related]  

  • 13. Reviewer's comment to Letter to the Editor of Jingming Lin et al. concerning "Comparison of unilateral versus bilateral pedicle screw fixation in lumbar interbody fusion: a meta-analysis" (by W. Ding et al. (2014) Eur Spine J 23(2):395-403): and authors' reply of Wenbin Ding et al.
    Edwards K
    Eur Spine J; 2015 Oct; 24(10):2357. PubMed ID: 26206291
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply. Letter to the editor. Hillemanns Peter, Hepp Hermann, Letter to the Editor: K. Gemzell-Danielsson et al. Emergency contraception - mechanisms of action.
    Gemzell-Danielsson K; Lalitkumar PG; Berger C
    Contraception; 2013 Oct; 88(4):581-2. PubMed ID: 23743446
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to the letter to the editor by Swarthout et al. (2018): Comments for Mertens et al. (2018), Glyphosate, a chelating agent-relevant for ecological risk assessment?
    Mertens M; Höss S; Neumann G; Afzal J; Reichenbecher W
    Environ Sci Pollut Res Int; 2018 Sep; 25(27):27664-27666. PubMed ID: 29862477
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to the letter to the editor by Somay et al: "In regard to recent published study of Lombardi et al. titled 'Pentoxifylline and tocopherol for prevention of osteoradionecrosis in patients who underwent oral surgery: A clinical audit".
    Lombardi N; Varoni E; Villa G; Salis A; Lodi G
    Spec Care Dentist; 2023; 43(4):507-508. PubMed ID: 36045508
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter to the Editor in Response to Manla et al: Reply to Manla Et Al, Re: Global Impact of the COVID-19 Pandemic on Solid Organ Transplant.
    Kute VB; Rane H; Chauhan S; Mishra V; Meshram HS
    Transplant Proc; 2022 Sep; 54(7):2044-2045. PubMed ID: 35934534
    [No Abstract]   [Full Text] [Related]  

  • 18. In reply to letter to the editor by Dr Willems et al. re: Eccles et al. Change in diffusion weighted MRI during liver cancer radiotherapy: Preliminary observations.
    Eccles C; Haider MA; Dawson LA
    Acta Oncol; 2010; 49(2):256-7. PubMed ID: 20017663
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to the Letter to the Editor of S. Shahsavari et al. concerning "Predicting medical complications in spine surgery: evaluation of a novel online risk calculator" by M. F. Kasparek et al. (Eur Spine J: doi: 10.1007/s00586-018-5707-9).
    Kasparek MF; Boettner F; Rienmueller A; Weber M; Funovics PT; Krepler P; Windhager R; Grohs J
    Eur Spine J; 2018 Nov; 27(11):2887-2888. PubMed ID: 30311038
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to the letter to the editor 'The ESMO Magnitude of Clinical Benefit Scaling Tool: from theory to practice' by Hartmann and the letter 'Comment on ESMO Magnitude of Clinical Benefit Scale' by Muhonen et al.
    Cherny NI; Sullivan R; Dafni U; Kerst JM; Sobrero A; Zielinski C; de Vries EGE; Piccart MJ
    Ann Oncol; 2016 Jan; 27(1):205-207. PubMed ID: 32645815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.